Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-06-29 Sale | 2021-06-30 7:01 pm | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 19,142 | $2.93 | $56,086 | 15,578 (Direct) | View |
2020-03-23 Sale | 2020-03-24 4:09 pm | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 834 | $27.42 | $22,868 | 31,267 (Direct) | View |
2020-01-21 Sale | 2020-01-23 4:06 pm | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 106,604 | $42.2 | $4,498,689 | 33,470 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 75,000 | $0 | 75,000 (Direct) | View |
2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
2021-07-01 Option Award | 2021-07-01 6:29 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
2021-06-29 Exercise | 2021-06-30 7:01 pm | N/A 2021-06-30 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 24,720 | $0 | 15,578 (Direct) | View |
2021-06-29 Exercise | 2021-06-30 7:01 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 24,720 | $2.2 | 15,578 (Direct) | View |
2020-07-01 Option Award | 2020-07-02 5:02 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 40,000 | $0 | 40,000 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 4,583 | $9.3 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 7,291 | $16.15 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A 2022-03-01 | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 106,604 | $0 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 20,000 | $5.34 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 20,000 | $11 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 15,000 | $7.35 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 9,000 | $7.36 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 17,360 | $15.25 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 3,370 | $29.8 | 33,470 (Direct) | View |
2020-01-21 Exercise | 2020-01-23 4:06 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer | 10,000 | $15.54 | 33,470 (Direct) | View |